Global Initiative for Asthma

According to the Global Initiative for Asthma (GINA, http //www.ginasthma.org), asthma affects about 300 million people worldwide. Men of all ages are affected by this chronic airway disorder that, without appropriate treatment, limits quality of life and is sometimes fatal. 

National Heart LaBI. NHLBI/WHO workshop report global strategy for asthma management and prevention. Global initiative for asthma. Bethesda National Heart, Lung and Blood Institute, 1995. 

Bousquet J Global initiative for asthma (GINA) and its objectives. Chn Exp Allergy 2000 30(suppl l) 2-5. 

O Byrne P, Bateman ED, Bousquet J, Clark T, Ohta K, Paggiaro P et al. From the Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2006. Available from URL http //www.ginasthma.org... 

Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. National Institutes of Health. National Hearth, Lung and Blood Institute. Revised 2002. www.ginasthma.com. (la)... 

Global Initiative for Asthma chapter 8 Socioeconomics. Publication 95-3659. Bethesda, National... 

Asthma (as defined by the Global Initiative for Asthma). Asthma is a chronic inflammatory disorder of the airways in which many cells play a role, in particular mast cells, eosinophils and T lymphocytes. In susceptible individuals this inflammation causes recurrent episodes of wheezing, breathlessness, chest tightness, and cough particularly at night and/or in the early morning. These symptoms are usually associated with widespread but variable airflow limitation that is at least partly reversible either spontaneously or with treatment. This inflammation also causes an associated increase in airway responsiveness to a variety of stimuli. 

NATIONAL INSTITUTES OF HEALTH (1995) Global Initiative for Asthma. Global strategy for asthma management and prevention NHBLI/WHO Workshop, NIH Publication 95-3659. 

Asthma has been known to be a risk factor for acute adverse reactions to contrast media [3 ]. A retrospective cohort study evaluated the risk of hypersensitivity reactions to contrast media in asthmatic patients by the severity of asthma. A total of 35,472 patients with 480 who had a hypersensitivity reaction were included in the study. Of the 480 patients who had a hypersensitivity reaction, 10 patients had as ma. Two hundred and sixty-six patients with as ma had no hypersensitivity reactions. When divided into five groups according to the Global Initiative for... 

---